Esperion Therapeutics, Inc. | Business Contracts

Form of Securities Purchase Agreement (Filed With SEC on March 22, 2023)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on March 22, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on March 22, 2023)

Form of Warrant Amendment Agreement (Filed With SEC on March 22, 2023)

Controlled Equity OfferingSM Sales Agreement, by and between Esperion Therapeutics, Inc. and Cantor Fitzgerald & Co., dated February 21, 2023 (Filed With SEC on February 21, 2023)

Waiver and Amendment No. 3 to Revenue Interest Purchase Agreement and Amendment No. 2 to Security Agreement, by and among the Registrant, the purchasers party thereto, and Eiger... (Filed With SEC on February 21, 2023)

Employment Agreement, dated November 16, 2022, by and between Esperion Therapeutics, Inc. and Benjamin Halladay (Filed With SEC on November 16, 2022)

Employment Agreement, dated June 9, 2022, by and between Esperion Therapeutics, Inc. and JoAnne Foody (Filed With SEC on June 13, 2022)

Employment Agreement, dated June 9, 2022, by and between Esperion Therapeutics, Inc. and Sheldon Koenig (Filed With SEC on June 13, 2022)

Employment Agreement, dated June 9, 2022, by and between Esperion Therapeutics, Inc. and Eric Warren (Filed With SEC on June 13, 2022)

Employment Agreement, dated June 9, 2022, by and between Esperion Therapeutics, Inc. and Benjamin Looker (Filed With SEC on June 13, 2022)

Employment Agreement, dated March 1, 2022, by and between Esperion Therapeutics, Inc. and Eric Warren (Filed With SEC on March 1, 2022)

Employment Agreement, dated January 1, 2022, by and between Esperion Therapeutics, Inc. and Benjamin O. Looker (Filed With SEC on January 4, 2022)

Form of Warrant to Purchase Common Stock (Filed With SEC on December 7, 2021)

Underwriting Agreement, dated December 2, 2021, between Esperion Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 7, 2021)

Exchange Agreement, dated October 22, 2021, by and between Esperion Therapeutics, Inc. and the Holders (Filed With SEC on October 25, 2021)

Amended and Restated Employment Agreement by and between the Registrant and Sheldon Koenig dated May 14, 2021 (Filed With SEC on August 3, 2021)

License and Collaboration Agreement, by and between the Registrant and Daiichi Sankyo Company, Limited dated April 26, 2021 (Filed With SEC on August 3, 2021)

Employment Agreement, dated June 28, 2021, by and between Esperion Therapeutics, Inc. and JoAnne Foody (Filed With SEC on June 28, 2021)

Agreement dated May 15, 2021 by and between Esperion Therapeutics, Inc. and Tim M. Mayleben (Filed With SEC on May 17, 2021)

2nd Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated March 19, 2021 (Filed With SEC on May 4, 2021)

Amendment No. 2 to Revenue Interest Purchase Agreement dated April 26, 2021 between the Company, Eiger Partners II LP and Eiger III SA LLC (Filed With SEC on April 26, 2021)

Employment Agreement by and between the Registrant and Ashley Hall effective August 28, 2015 (Filed With SEC on February 23, 2021)

Employment Agreement by and between the Registrant and Sheldon Koenig effective December 15, 2020 (Filed With SEC on February 23, 2021)

Amendment No. 1 to the Revenue Interest Purchase Agreement, dated November 11, 2020, by and among the Company, the purchasers from time to time party thereto and Eiger III SA LLC,... (Filed With SEC on February 23, 2021)

Indenture, dated as of November 16, 2020, between Esperion Therapeutics, Inc. and U.S. Bank National Association (Filed With SEC on November 16, 2020)

Form of Capped Call Confirmation (Filed With SEC on November 16, 2020)

Forward Stock Purchase Confirmation, dated November 11, 2020, between Esperion Therapeutics, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on November 16, 2020)

1st Amendment to the License and Collaboration Agreement by and between the Registrant and Daiichi Sankyo Europe GMBH dated June 18, 2020 (Filed With SEC on August 10, 2020)

License and Collaboration Agreement by and between the Registrant and Otsuka Pharmaceutical Co., Ltd. dated April 17, 2020 (Filed With SEC on August 10, 2020)

Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended (Filed With SEC on August 10, 2020)

Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on May 29, 2020)

First Amendment to 2017 Inducement Equity Plan (Filed With SEC on February 27, 2020)

Description of Registrant's Securities (Filed With SEC on February 27, 2020)

Revenue Interest Purchase Agreement by and between the Company, Eiger III SA LLC, and the Purchasers named therein, dated June 26, 2019 (Filed With SEC on June 26, 2019)

Employment Agreement by and between the Registrant and Mark Glickman dated March 14, 2018 (Filed With SEC on February 28, 2019)

Employment Agreement by and between the Registrant and Richard B. Bartram dated May 14, 2015 (Filed With SEC on February 28, 2019)

License and Collaboration Agreement by and between Daiichi Sankyo Europe GmbH and the Company, dated as of January 2, 2019 (Filed With SEC on February 28, 2019)

First Amendment to Valley Ranch Business Park Lease, dated July 6, 2018, between the Registrant and Blackbird Ann Arbor, LLC (Filed With SEC on August 2, 2018)

UNDERWRITING AGREEMENT Esperion Therapeutics, Inc. 3,100,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on August 10, 2017)

AMENDED AND RESTATED ESPERION THERAPEUTICS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on November 3, 2016)

TERMINATION AGREEMENT (Filed With SEC on December 3, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on June 15, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on May 20, 2015)

UNDERWRITING AGREEMENT Esperion Therapeutics, Inc. 1,750,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on March 19, 2015)

UNDERWRITING AGREEMENT Esperion Therapeutics, Inc. 4,250,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on October 16, 2014)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 12, 2014)

3891 Ranchero Drive, Suite 150 Ann Arbor, MI 48108 (Filed With SEC on July 31, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on July 2, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on July 2, 2014)

SECOND AMENDMENT TO LEASE (Filed With SEC on August 27, 2013)

[] Shares Esperion Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 12, 2013)

ESPERION THERAPEUTICS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on June 12, 2013)

ESPERION THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on June 7, 2013)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 14, 2013)

WARRANT TO PURCHASE PREFERRED STOCK (Filed With SEC on May 14, 2013)

HDL THERAPEUTICS, INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 14, 2013)

AMENDMENT NO. 1 TO INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 14, 2013)

HDL THERAPEUTICS, INC. REGISTRATION RIGHTS AND SECURITYHOLDER AGREEMENT (Filed With SEC on May 14, 2013)

HDL THERAPEUTICS, INC. 2008 INCENTIVE STOCK OPTION AND RESTRICTED STOCK PLAN (Filed With SEC on May 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2013)

LICENSE AGREEMENT between PFIZER, INC. and ESPERION THERAPEUTICS, INC. (Filed With SEC on May 14, 2013)

ESPERION THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on May 14, 2013)

ESPERION THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on May 14, 2013)

Amendment to Collaboration & License Agreement (Filed With SEC on December 23, 2003)

Amendment #3 to the Rights Agreement (Filed With SEC on December 23, 2003)

2000 Equity Compensation Plan (Filed With SEC on November 10, 2003)

Loan and Security Agreement (Filed With SEC on November 10, 2003)

EX-10.55 Advisory Services Agreement (Filed With SEC on August 14, 2003)

EX-10.56 Employment Agreement - Adeoye Y. Olukotun (Filed With SEC on August 14, 2003)

EX-10.57 Amend. No. 1 to 2000 Equity Compensation (Filed With SEC on August 14, 2003)

EX-10.58 Office Lease - State 94 Properties, LLC (Filed With SEC on August 14, 2003)

Employment Arrangement Between Frank Thomas (Filed With SEC on March 26, 2003)

Employment Arrangment Between Jean-Louis Dasseux (Filed With SEC on March 26, 2003)

Employement Arrangement Between Brian R. Krause (Filed With SEC on March 26, 2003)

Employment Arrangement Bet. Timothy M. Mayleben (Filed With SEC on March 26, 2003)

Employment Arrangement Between Roger S. Newton (Filed With SEC on March 26, 2003)

Lease Extension - Third Renewal Term (Filed With SEC on March 26, 2003)

Second Amendment to Commercial Sublease Agreement (Filed With SEC on March 26, 2003)

Confirmation of Sublease Terms (Filed With SEC on March 14, 2002)

Loan Modification Agreement (Filed With SEC on March 14, 2002)

Loan & Security Agreement (Filed With SEC on March 14, 2002)

Memorandum of Understanding (Filed With SEC on March 14, 2002)

Esperion Therapeutics, Inc. (87)